Michelle Fodor

Novartis (United States)

Papers

1

Total Citations

17

H-Index

1

About

Michelle Fodor is a structural biologist and microfluidics innovator whose work bridges the gap between high-throughput screening and protein crystallography. Her primary research focuses on developing capillary-based microfluidic platforms to enable rapid, room-temperature X-ray crystallographic screening of small-molecule compounds—a critical step in drug discovery. Her most cited work, a 2021 study detailing a novel microfluidic device fabricated from UV-curable polymers via cleanroom photolithography, has already garnered 17 citations for its transformative approach to accelerating compound screening while preserving protein crystal integrity. By eliminating the need for cryogenic conditions, Fodor’s devices allow researchers to observe protein-ligand interactions under more physiologically relevant conditions, improving the efficiency of early-stage drug development. Her contributions represent a significant advance in structural biology, offering a practical, scalable solution for high-throughput crystallography. Fodor’s work is particularly notable for its interdisciplinary nature, merging microfluidics, materials science, and structural biology to solve a longstanding bottleneck in the field. For students and researchers, her innovations exemplify how engineering principles can directly enhance biological discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screening
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Novartis (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago